261 related articles for article (PubMed ID: 11822980)
1. Hormone replacement therapy trials: an update.
Duvernoy CS; Mosca L
Curr Atheroscler Rep; 2002 Mar; 4(2):156-60. PubMed ID: 11822980
[TBL] [Abstract][Full Text] [Related]
2. Selective estrogen receptor modulators and phytoestrogens: new therapies for the postmenopausal women.
Fitzpatrick LA
Mayo Clin Proc; 1999 Jun; 74(6):601-7. PubMed ID: 10377937
[TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy, selective estrogen receptor modulators, and tissue-specific compounds: cardiovascular effects and clinical implications.
Vogelvang TE; van der Mooren MJ; Mijatovic V
Treat Endocrinol; 2004; 3(2):105-15. PubMed ID: 15743106
[TBL] [Abstract][Full Text] [Related]
4. Role of estrogens, selective estrogen receptor modulators and phytoestrogens in cardiovascular protection.
Herrington D
Can J Cardiol; 2000 Aug; 16 Suppl E():5E-9E. PubMed ID: 10906617
[TBL] [Abstract][Full Text] [Related]
5. [Phytoestrogens and SERMS, alternatives to classical hormone therapy?].
Huber J
Ther Umsch; 2000 Oct; 57(10):651-4. PubMed ID: 11081378
[TBL] [Abstract][Full Text] [Related]
6. Estrogen: new and old choices.
Miller CA
Geriatr Nurs; 1999; 20(6):330-1. PubMed ID: 10601900
[No Abstract] [Full Text] [Related]
7. Cardiovascular actions of selective estrogen receptor modulators and phytoestrogens.
Nandur R; Kumar K; Villablanca AC
Prev Cardiol; 2004; 7(2):73-9. PubMed ID: 15133375
[TBL] [Abstract][Full Text] [Related]
8. Bioidentical hormone replacement therapy. Customizing care for perimenopausal and menopausal women.
Romero M
Adv Nurse Pract; 2002 Nov; 10(11):47-8, 51-2. PubMed ID: 12478948
[No Abstract] [Full Text] [Related]
9. Soy phytoestrogens: an adjunct to hormone replacement therapy?
Birge SJ
Menopause; 2000; 7(4):209-12. PubMed ID: 10914612
[No Abstract] [Full Text] [Related]
10. Estrogen replacement therapy, atherosclerosis, and vascular function.
Mikkola TS; Clarkson TB
Cardiovasc Res; 2002 Feb; 53(3):605-19. PubMed ID: 11861031
[TBL] [Abstract][Full Text] [Related]
11. The effects of estrogen and selective estrogen receptor modulators on cardiovascular risk factors.
Walsh BW
Ann N Y Acad Sci; 2001 Dec; 949():163-7. PubMed ID: 11795349
[TBL] [Abstract][Full Text] [Related]
12. Use of alternatives to estrogen for treatment of menopause.
Pinkerton JV; Santen R
Minerva Endocrinol; 2002 Mar; 27(1):21-41. PubMed ID: 11845111
[TBL] [Abstract][Full Text] [Related]
13. Estrogen, selective estrogen receptor modulation, and coronary heart disease: something or nothing.
Jordan VC
J Natl Cancer Inst; 2001 Jan; 93(1):2-4. PubMed ID: 11136828
[No Abstract] [Full Text] [Related]
14. Alternatives to estrogen replacement therapy.
Maroulis GB
Ann N Y Acad Sci; 2000; 900():413-5. PubMed ID: 10818430
[No Abstract] [Full Text] [Related]
15. Prevention of postmenopausal osteoporosis with oestrogen replacement therapy and associated compounds: update on clinical trials since 1995.
Dören M; Samsioe G
Hum Reprod Update; 2000; 6(5):419-26. PubMed ID: 11045872
[TBL] [Abstract][Full Text] [Related]
16. [Primary and secondary prevention of cardiovascular events through hormone replacement therapy (HRT)].
Pilz H
Wien Med Wochenschr; 2005 Sep; 155(17-18):397-403. PubMed ID: 16392437
[TBL] [Abstract][Full Text] [Related]
17. [Specific estrogen receptor modulators (SERMs)].
Trémollières F; Lopes P
Presse Med; 2002 Sep; 31(28):1323-8. PubMed ID: 12355995
[TBL] [Abstract][Full Text] [Related]
18. [Menopause. The gynecologist's point of view].
Rev Infirm; 2000 Jan; (56):26-7. PubMed ID: 10876568
[No Abstract] [Full Text] [Related]
19. Estrogens and lipids. Can HRT designer estrogens, and phytoestrogens reduce cardiovascular risk markers after menopause?
Ariyo AA; Villablanca AC
Postgrad Med; 2002 Jan; 111(1):23-30; quiz 3. PubMed ID: 11810749
[TBL] [Abstract][Full Text] [Related]
20. [The current state of hormonal prevention of coronary heart disease in menopausal women].
Wenger NK
Rev Esp Cardiol; 2003 Jan; 56(1):1-8. PubMed ID: 12549992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
